Last updated at 07 Dec 2025 10:45 AM
Director
DIN: 09472421
Harshkumar Vinodbhai Arvadia is currently associated with 2 companies in various capacities such as Director, Individual Promoter and Designated Partner. They serve as a Director at MATRI-PRERNA HERBALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09472421.Harshkumar Vinodbhai Arvadia is currently involved in 3 different roles. Their most recent position is with ICONE PROGRESSION LLP as a Designated Partner. The first company Harshkumar Vinodbhai Arvadia was appointed to as a director was MATRI-PRERNA HERBALS PRIVATE LIMITED. Harshkumar Vinodbhai Arvadia is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Harshkumar Vinodbhai Arvadia is currently associated with 2 companies in various capacities such as Director, Individual Promoter and Designated Partner. They serve as a Director at MATRI-PRERNA HERBALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09472421.Harshkumar Vinodbhai Arvadia is currently involved in 3 different roles. Their most recent position is with ICONE PROGRESSION LLP as a Designated Partner. The first company Harshkumar Vinodbhai Arvadia was appointed to as a director was MATRI-PRERNA HERBALS PRIVATE LIMITED. Harshkumar Vinodbhai Arvadia is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (0)
10 Months 5 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| MATRI-PRERNA HERBALS PRIVATE LIMITED | Director | 18-Jan-2022 |
| MATRI-PRERNA HERBALS PRIVATE LIMITED | Individual Promoter | 18-Jan-2022 |